Permanent Supportive Housing Overdose Prevention-2 Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

2940 participants

Study Classification

INTERVENTIONAL

Study Start Date

2027-07-01

Study Completion Date

2031-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This community-partnered study examines a technical assistance intervention designed to help permanent supportive housing agencies implement evidence-based practices to prevent tenant overdose and improve tenant health.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Permanent Supportive Housing Overdose Prevention

NCT05786222

Overdose

ENROLLING_BY_INVITATION NA

Preventing Overdose Using Information and Data From the Environment

NCT05096429

Opioid Overdose Drug Overdose

COMPLETED NA

Overdose Prevention Centers and Behavioral Health

NCT06236087

Overdose

NOT_YET_RECRUITING

Subthreshold Opioid Use Disorder Prevention (STOP) Trial

NCT04218201

Opioid-use Disorder

COMPLETED NA

Kentucky Women's Justice Community Overdose Innovation Network - Phase II

NCT07179614

Overdose Risk Opioid Use Disorder Stimulant Use Disorders

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Homelessness and housing instability are strongly linked with overdose risk. Permanent supportive housing (PSH) -subsidized housing paired with supportive services-is a key strategy to end homelessness yet supportive housing tenants face high overdose risk due to a confluence of factors. This multi-sector, community-partnered, stepped wedge randomized controlled trial evaluates the impact of a technical assistance intervention designed to support supportive housing agencies in sustainably implementing evidence-based practices to reduce tenant overdose and improve tenant health more broadly. The technical assistance intervention will be delivered to supportive housing agencies in New Jersey and New York who are enrolled in the trial. Outcomes include PSH agency implementation of overdose prevention practices and downstream tenant overdose, substance use, and other health-related outcomes. Outcomes will be assessed using surveys, administrative data, and agency records. This trial is a part of the HEAL Initiative (https://heal.nih.gov/).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overdose Substance Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Wave 1: Control, Intervention, Sustainment

Participants at agencies assigned to wave 1 will receive the control condition from months 1-6; intervention for months 6-12; and sustainment from months 12-45.

Group Type EXPERIMENTAL